UNSPSC 51191577: Furosemide xantinol

This classification denotes a loop diuretic C13H21N5O4.C12H11ClN2O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y1P3P1MD0G, chemically known as benzoic acid, 5-(aminosulfonyl)-4-chloro-2-((2-furanylmethyl)amino)-, compd. with 3,7-dihydro-7-(2-hydroxy-3-((2-hydroxyethyl)methylamino)propyl)-1,3-dimethyl-1h-purine-2,6-dione (1:1), but more generally known as furosemide xantinol, which bears US NIH Compound Identifier 71587213.

UNSPSC 51191577 Furosemide xantinol is a Commodity code that does not map to recent state and local procurement activity. The three most recent opportunities tagged under this code involve wastewater treatment valve services (Broward County, Florida), parenteral nutrition and intravenous solutions for correctional healthcare (Washington State Department of Corrections), and sodium bisulfite chemical supply for municipal water treatment (City of Meriden, Connecticut). None of these solicitations concern furosemide or pharmaceutical products generally — the code's nominal scope — and appear to reflect misclassification in the source system rather than legitimate procurement under this Commodity.

The issuing bodies include a county water authority, a state correctional agency, and a municipal water utility, representing different service lines (wastewater infrastructure, correctional healthcare, municipal water treatment) with no thematic connection to furosemide. The geographic footprint spans Florida, Washington, and Connecticut. Without recent opportunities that align to furosemide procurement, the code shows no actionable market signal for vendors in pharmaceutical supply or distribution.